KRT20 and intrahepatic cholangiocarcinoma: In a study of 89 patients with superficial UC, those who experienced recurrence during a 36-month follow-up period showed significantly higher overexpression of CK20 (63.4%) compared to those without recurrence (42.8%) in the context of CK20 ICC (40).